FcRn-targeted Mucosal Vaccination Against RSV
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- UNIVERSITY OF MARYLAND, College Park, Maryland has been assigned a patent (No. US 12138306 B2, initially filed June 3, 2022) developed by Xiaoping Zhu, Clarksville, Maryland, and Weizhong Li, College Park, Maryland, for "FcRn-targeted mucosal vaccination against RSV." . . .